Skip to content
Dose Brief
Menu

Vytora Health review

By Updated

Monthly and prepaid compound plans, plus branded tirzepatide, with conflicting tirzepatide price displays.

Brief Score87/100Grade B+No. 13 in our directory
Visit Vytora Health View the provider’s current plans and terms.
Semaglutide

$179/mo

Three-month option: $447 upfront ($149/mo equivalent).

Full price details

$179/mo; $447 prepaid for 3 months

Tirzepatide

Quote needs confirmation

Treatment card: $249/mo; FAQ: $199/mo.

Quarterly figures also disagree; confirm the full charge.

Full price details

Conflicting $249 and $199 monthly quotes; confirm

Coverage
Advertises all 50 states and DC; product availability varies
Brand-name
Yes

Prices checked against Vytora Health's published terms in . Providers change pricing without notice — check the current figure before you buy.

On the trackerNewnew to the tracker, no prior reading— Semaglutide is $179 monthly or $447 for three months. Tirzepatide prices conflict across the page; get the exact total before paying.

Vytora Health in depth

Vytora Health offers compounded weekly injections with medication, clinician care, supplies and shipping included. Semaglutide is listed at $179 for a monthly plan or $447 prepaid for three months, equivalent to $149 a month. The shorter plan costs more per month but avoids committing to three months at once. Vytora also includes provider messaging, follow-ups and a portal for refills and shipment updates.

Tirzepatide needs a written quote before it can be compared reliably. The live treatment card says $249 monthly, while the FAQ says $199 for a one-month plan. Its quarterly FAQ also pairs $199 a month with a $599 total, which does not equal three payments of $199. These are conflicting offers on the same site, not a verified price range. Confirm the full charge, duration and renewal amount for your selected plan rather than relying on the lowest number.

Vytora separately lists Mounjaro and Zepbound at $1,399 a month, described as retail pricing that may vary. Those are branded tirzepatide routes and are distinct from the compound prices. RxSpan MD itemizes a cash-pay brand-name lane on the same price list as its compounded lines. The current page does not promise insurance authorization services. It also cautions that prices may vary by dosage and treatment, so the compound headline should not be read as a universal all-dose guarantee.

The site identifies Wasef Health as the clinical group and names Vials Pharmacy and Hallandale Pharmacy as partners. It advertises service in all 50 states and DC, with individual pharmacies licensed in selected states. That network description does not establish which pharmacy will fill your prescription. Ask for that assignment and the exact formulation; compounded prescriptions are not FDA-approved finished products.

Hallandale has relevant dated regulatory history. FDA’s May 3, 2022 closeout said the violations cited in its March 11, 2020 warning letter appeared adequately addressed. That is pharmacy-specific historical context, not a warning letter to Vytora, proof of your assigned pharmacy or a determination of current conditions. Naming a pharmacy is useful transparency, but it does not replace checking the pharmacy on your own prescription.

Vytora says subscriptions renew automatically and can be canceled by emailing support. Its refund policy states prescription sales are final and directs dispensing-error concerns to support. Cancellation therefore should not be assumed to refund an existing order. The clear semaglutide monthly option is easier to evaluate than the contradictory tirzepatide offer; resolve those figures and your dispensing arrangement before choosing a prepaid plan.

Sources we checked

Public program pages and terms, checked October 2026. We have not enrolled in treatment or independently tested the medication.

This source update covers the review text and stated program terms. The existing numerical score has not been recalculated from this check; it should not be read as a new validation of every score factor.

The scorecard

Vytora Health scored on our six Brief Score factors. See the methodology.

Price Stability85/100
Supply Reliability87/100
Transparency88/100
Access Breadth90/100
Clinical Oversight88/100
Track Record82/100

What we like

  • Semaglutide monthly and quarterly totals published
  • Names clinical group and pharmacy partners
  • Provider messaging and shipping included

The caveats

  • Tirzepatide card and FAQ disagree
  • Prescription sales are final
  • Published prices may vary by dose and treatment

The brief

Best for: Comparing monthly semaglutide with a prepaid option and named clinical/pharmacy partners. Monthly and prepaid compound plans, plus branded tirzepatide, with conflicting tirzepatide price displays.

Ranked #13 of 546 providers we reviewed — compare with CoreAge Rx, for comparison.

Before you decide

The questions readers ask next after reading about Vytora Health.

Closest here

The providers scoring nearest Vytora Health — read each current assessment before choosing care.

Weighing Vytora Health against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs Vytora Health, and every provider that outranks it is listed on the Vytora Health alternatives ranking.

Other head-to-head comparisons for Vytora Health include Effecty and RxSpan MD.

More providers we track (24)

514 more are filed too — see every provider we track, ranked.

Pricing, states and verification reflect Vytora Health's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on Vytora Health's site. Not medical advice; see our disclosure.

← Back to all rankings